Business Description
Invivyd Inc
NAICS : 325412
SIC : 2834
ISIN : US00534A1025
Share Class Description:
IVVD: Ordinary SharesTotal Employee Number:
122Description
Invivyd Inc is a biopharmaceutical company focused on the discovery, development, and commercialization of monoclonal antibody (mAb) therapies for the prevention and treatment of serious viral infectious diseases. Its lead product, PEMGARDA (pemivibart), received emergency use authorization from the U.S. FDA for the pre-exposure prevention of COVID-19 in certain immunocompromised individuals. The company is also developing next-generation antibody candidates, including VYD2311 for COVID-19 and VBY329 for RSV infections, while continuing research on additional antibodies targeting other viral diseases such as measles.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 21.35 | |||||
Equity-to-Asset | 0.84 | |||||
Debt-to-Equity | 0.04 | |||||
Debt-to-EBITDA | -0.11 | |||||
Interest Coverage | N/A |
N/A
|
N/A
| |||
Piotroski F-Score | 2/9 | |||||
Altman Z-Score | -2.04 | |||||
Beneish M-Score | -1.8 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 47 | |||||
3-Year EPS without NRI Growth Rate | 47.1 | |||||
3-Year FCF Growth Rate | 45.1 | |||||
3-Year Book Growth Rate | -36 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 24.01 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 55.3 |
Momentum Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 33.99 | |||||
9-Day RSI | 37.28 | |||||
14-Day RSI | 38.04 | |||||
3-1 Month Momentum % | -48.81 | |||||
6-1 Month Momentum % | -64.25 | |||||
12-1 Month Momentum % | 20.86 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 6.47 | |||||
Quick Ratio | 6.46 | |||||
Cash Ratio | 5.82 | |||||
Days Inventory | 33.86 | |||||
Days Sales Outstanding | 68.83 | |||||
Days Payable | 1122.48 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -37.3 | |||||
Shareholder Yield % | -1.18 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 92.94 | |||||
Operating Margin % | -146.38 | |||||
Net Margin % | -138.9 | |||||
EBITDA Margin % | -143.01 | |||||
FCF Margin % | -142.22 | |||||
OCF Margin % | -140.91 | |||||
ROE % | -61.14 | |||||
ROA % | -45.61 | |||||
ROIC % | -234.14 | |||||
3-Year ROIIC % | 752.21 | |||||
ROC (Joel Greenblatt) % | -1642.58 | |||||
ROCE % | -63.26 | |||||
Moat Score | 3 | |||||
Tariff Resilience Score | 5 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Forward PE Ratio | 3.99 | |||||
PS Ratio | 2.77 | |||||
PB Ratio | 1.09 | |||||
Price-to-Tangible-Book | 1.09 | |||||
EV-to-EBIT | -0.68 | |||||
EV-to-EBITDA | -0.69 | |||||
EV-to-Forward-EBITDA | -0.39 | |||||
EV-to-Revenue | 0.99 | |||||
EV-to-Forward-Revenue | 0.77 | |||||
EV-to-FCF | -0.7 | |||||
| Price-to-Net-Current-Asset-Value | 1.33 | |||||
| Price-to-Net-Cash | 1.54 | |||||
Earnings Yield (Greenblatt) % | -147.06 | |||||
FCF Yield % | -34.43 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:IVVD
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return %
Total Annual Return %
Invivyd Inc Executives
DetailsGF Value™
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 55.866 | ||
| EPS (TTM) ($) | -0.349 | ||
| Beta | 1.1992 | ||
| 3-Year Sharpe Ratio | 0.5 | ||
| 3-Year Sortino Ratio | 1.38 | ||
| Volatility % | 98.62 | ||
| 14-Day RSI | 38.04 | ||
| 14-Day ATR ($) | 0.093297 | ||
| 20-Day SMA ($) | 0.877875 | ||
| 12-1 Month Momentum % | 20.86 | ||
| 52-Week Range ($) | 0.483 - 3.0699 | ||
| Shares Outstanding (Mil) | 294.61 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Invivyd Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Invivyd Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| Third quarter earnings conference call for 2026 | 2026-11-06 08:30 | In 119 days | ||
| Third quarter earnings results for 2026 | 2026-11-06 | In 118 days | ||
| Second quarter earnings results for 2026 | 2026-08-14 | In 34 days | ||
| Guidance call for 2026 | 2026-06-16 | 0.87 (+8.58%) | ||
| H.C. Wainwright “HCW @ Home” Series | 2026-06-08 10:00 | 1.03 (-8.85%) | ||
| Guidance call for 2026 | 2026-06-03 16:55 | 1.14 (-6.56%) | ||
| General meeting for 2026 | 2026-05-19 08:30 | 1.13 (-6.61%) | ||
| First quarter earnings conference call for 2026 | 2026-05-14 08:30 | 1.47 (-1.34%) | ||
| First quarter earnings results for 2026 | 2026-05-14 | 1.47 (-1.34%) | ||
| Fourth quarter earnings conference call for 2025 | 2026-03-05 08:30 | 1.71 (+3.64%) |
Show
Entries
Invivyd Inc Frequently Asked Questions
What is Invivyd Inc(IVVD)'s stock price today?
The current price of IVVD is $0.79. The 52 week high of IVVD is $3.07 and 52 week low is $0.48.
When is next earnings date of Invivyd Inc(IVVD)?
The next earnings date of Invivyd Inc(IVVD) is 2026-08-14 Est..
Does Invivyd Inc(IVVD) pay dividends? If so, how much?
Invivyd Inc(IVVD) does not pay dividend.
Guru Commentaries on NAS:IVVD
No articles.
Press Release
Articles on Invivyd Inc
Headlines
See More- 1
Jul 06, 2026
Invivyd gets notice of Pemgarda EUA termination
Seeking Alpha • 6:36am
- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers